Cytomegalovirus infection and cardiac allograft vasculopathy in children

Circulation

Volumn 115, Issue 13, 2007, Pages 1701-1702

  Webber, Steven A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Editorials; Grafting; Immune system; Transplantation; Viruses

Indexed keywords

GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; VALGANCICLOVIR; ANTIVIRUS AGENT; VIRUS ANTIBODY;

BLOOD TRANSFUSION; CARDIAC ALLOGRAFT VASCULOPATHY; CHILDHOOD DISEASE; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EDITORIAL; EPIDEMIOLOGICAL DATA; EPSTEIN BARR VIRUS; GRAFT RECIPIENT; HERPES SIMPLEX VIRUS; HERPES VIRUS; HERPES VIRUS INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; MORBIDITY; MORTALITY; ORGAN DONOR; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; VIRUS PATHOGENESIS; ALLOTRANSPLANTATION; BLOOD; CHILD; CYTOMEGALIC INCLUSION BODY DISEASE; DONOR; FOLLOW UP; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGY; NOTE; PATHOGENICITY; POSTOPERATIVE COMPLICATION; PREMEDICATION; RETROSPECTIVE STUDY; RISK FACTOR; SAMPLE SIZE; TREATMENT OUTCOME; VIROLOGY; VIRUS INFECTION; VIRUS LATENCY;

ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CHILD; CORONARY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; RETROSPECTIVE STUDIES; RISK FACTORS; SAMPLE SIZE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIRUS DISEASES; VIRUS LATENCY;

EID: 34247179587     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.686709     Document Type: Editorial

References (14)

1. Valantine HA. The role of viruses in cardiac allograft vasculopathy. Am J Transplant. 2003;4:169-177.
2. Webber SA, Naftel DC, Fricker FJ, Olesnevich P, Blume ED, Addonizio L, Kirklin JK, Canter CE and the Pediatric Heart Transplant Study. Lymphoproliferative disorders following pediatric heart transplantation: a multi-institutional study. Lancet. 2006;367:233-239.
3. Kanter K, Naftel DC, Pahl E, Canter CE, Webber SA, Vincent RN, Kirklin JK, Morrow WR, and the Pediatric Heart Transplant Study Group. Cytomegalovirus prophylaxis and infection in pediatric heart transplant recipients. J Heart Lung Transplant. 2004;23:S126-S127.
4. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989;261:3561-3566.
5. Peersons MC, Stals FS, van dam Mieras MC, Bruggeman CA. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. J Pathol. 1998;184:103-109.
6. Wu TC, Hruban RH, Ambinder RF, Pizzorno M, Cameron DE, Baumgartner WA, Reitz BA, Hayward GS, Hutchins GM. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol. 1992;140:739-747.
7. Lemstrom K, Sihvola R, Bruggeman C, Hayry P, Koskinen P. Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation. 1997;95:2614-2616.
8. Valantine HA, Gao SZ, Menon SG, Renlund DG, Hunt SA, Oyer P, Stinson EB, Brown BW Jr, Merigan TC, Schroeder JS. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation. 1999;100:61-66.
9. Fukushima N, Gundry SR, Razzouk AJ, Bailey LL. Cytomegalovirus infection in pediatric heart transplantation. Transplant Proc. 1993;25:1423-1425.
10. Hussain T, Burch M, Fenton MJ, Whitmore PM, Rees P, Elliot M, Aurora P. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children. Circulation. 2007;115:1798-1805.
11. Pahl E, Naftel DC, Kuhn MA, Shaddy RE, Morrow WR, Canter CE, Kirklin J. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study. J Heart Lung Transplant. 2005;24:645-651.
12. Petrakopoulou P, Kubrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, Weis M. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation. 2004;110(suppl II):II-207-II-212.
13. Douche-Aourik F, Bourlet T, Mosnier JF, Jacques J, Decoene C, Stankowiak C, Pozzetto B, Andreoletti L. Association between enterovirus endomyocardial infection and late severe cardiac events in some adult patients receiving heart transplants. J Med Virol. 2005;75:47-53.
14. Shirali GS, Ni J, Chinnock RE, Johnston JK, Rosenthal GL, Bowles NE, Towbin JA. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med. 2001;344:1498-1503.